Leukoencephalopathy resolution after atypical mycobacterial treatment: a case report
- PMID: 26329680
- PMCID: PMC4557863
- DOI: 10.1186/s12883-015-0415-0
Leukoencephalopathy resolution after atypical mycobacterial treatment: a case report
Abstract
Background: Association of leukoencephalopathy and atypical mycobacteriosis has been rarely reported. We present a case that is relevant for its unusual presentation and because it may shed further light on the pathogenic mechanisms underlying reversible encephalopathies.
Case report: We report the case of a Hispanic 64-year-old woman with cognitive decline and extensive leukoencephalopathy. Magnetic resonance imaging revealed white-matter lesions with increased water diffusivity, without blood-brain-barrier disruption. Brain biopsy showed tissue rarefaction with vacuolation, mild inflammation, few reactive astrocytes and decreased aquaporin water-channel expression in the lesions. Six months later, she was diagnosed with atypical mycobacterial pulmonary infection. Brain lesions resolved after antimycobacterial treatment.
Conclusion: We hypothesize leukoencephalopathic changes and vasogenic edema were associated with decreased aquaporin expression. Further studies should clarify if reversible leukoencephalopathy has a causal relationship with decreased aquaporin expression and atypical mycobacterial infection, and mechanisms underlying leukoencephalopathy resolution after antimycobacterial treatment. This article may contribute to the understanding of pathogenic mechanisms underlying magnetic resonance imaging subcortical lesions and edema, which remain incompletely understood.
Figures


Similar articles
-
Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).Thorax. 2017 Nov;72(11):969-970. doi: 10.1136/thoraxjnl-2017-210929. Thorax. 2017. PMID: 29054887
-
Management of nontuberculous mycobacterial (NTM) lung disease.Semin Respir Crit Care Med. 2013 Feb;34(1):135-42. doi: 10.1055/s-0033-1333575. Epub 2013 Mar 4. Semin Respir Crit Care Med. 2013. PMID: 23460013
-
Antibiotic treatment for nontuberculous mycobacterial lung disease.Expert Rev Respir Med. 2016;10(5):557-68. doi: 10.1586/17476348.2016.1165611. Epub 2016 Mar 30. Expert Rev Respir Med. 2016. PMID: 26967761 Review.
-
Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.South Med J. 2010 Aug;103(8):828-30. doi: 10.1097/SMJ.0b013e3181e6cc26. South Med J. 2010. PMID: 20622732
-
Nontuberculous mycobacterial disease in childhood - update on diagnostic approaches and treatment.J Infect. 2017 Jun;74 Suppl 1:S136-S142. doi: 10.1016/S0163-4453(17)30204-9. J Infect. 2017. PMID: 28646953 Review.
Cited by
-
Progressive Cerebral Small Vessel Disease Caused by an Autoimmune Response to Intravesical Bacille-Calmette-Guérin Treatment.Front Neurol. 2020 Oct 26;11:484282. doi: 10.3389/fneur.2020.484282. eCollection 2020. Front Neurol. 2020. PMID: 33192960 Free PMC article.
-
Mycobacterium celatum encephalitis in an immunocompromised host mimicking autoimmune striatal encephalitis: the first case report.BMC Infect Dis. 2025 Mar 6;25(1):321. doi: 10.1186/s12879-025-10602-5. BMC Infect Dis. 2025. PMID: 40050751 Free PMC article.
References
-
- Lee VH, Wijdicks EM, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205–210. - PubMed
-
- Magaña SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology. 2009;72(8):712–717. doi: 10.1212/01.wnl.0000343001.36493.ae. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical